Home » Newsletters » BioWorld Science

BioWorld Science

July 27, 2017

View Archived Issues

Neon and Apexigen enter clinical trial collaboration to test NEO-PV-01 with APX-005M in melanoma

Amgen profiles product and pipeline progress of second quarter 2017

FDA issues complete response letter for Ryanodex

MK-8591 shows promise as a novel HIV prophylaxis drug in preclinical and early clinical setting

AstraZeneca and Merck & Co. collaborate on Lynparza

Bavarian Nordic and Janssen collaborate on vaccine regimens for HBV and HIV

STAT6 downregulation in glioblastoma allows cancer cell survival

Emergent BioSolutions signs Zika licensing agreement with Valneva

European Commission approves Orencia for psoriatic arthritis

Compugen and Bayer update collaboration agreement to focus on CGEN-15001T program

Vosevi now available in U.S.

FDA grants orphan drug designation to delpazolid for the treatment of tuberculosis

BioCardia completes roll-in cohort in CardiAMP heart failure trial

Barbiturate/thiobarbiturate derivatives show promise for hair growth

PFS endpoint not met in MYSTIC NSCLC trial of Imfinzi plus tremelimumab

Chondrial's CTI-1601 receives U.S. orphan status for Friedreich's ataxia

European approval for Faslodex as first-line therapy for advanced postmenopausal breast cancer

PellePharm's patidegib named orphan drug for Gorlin syndrome

Phase III FLAURA trial shows PFS benefit with Tagrisso in first-line EGFRm-positive NSCLC

FDA approves Fycompa as monotherapy for partial-onset seizures

AbbVie initiates phase I study of ABBV-176 in advanced solid tumors likely to express PRLR

Novartis studies LML-134 for proof of concept in shift work disorder

UHRF1 promotes methylation-driven repression of latent HIV-1

Aelix conducts phase I trial of DNA.HTI and MVA.HTI in HIV-1-positive patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...